Nemaura Medical Inc.
Company Snapshot: Nemaura Medical Inc.
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes specialty medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. The company was founded in 2009 and is headquartered in Loughborough, the United Kingdom.
- May 20 2020 Nemaura Medical 2020 Stock Incentive Plan Approved at Annual General Meeting
- May 11 2020 Nemaura reports positive data from early head-to-head comparison with a major incumbent CGM Device
- May 5 2020 Nemaura Medical Announces Interview with CEO to Air on May 11
- Apr 21 2020 Nemaura Secures $5 Million Loan to Accelerate Commercial Strategy